Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea Bentow

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Clinical Chemistry and Laboratory Medicine|July 19, 2019
Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experienceMaria Infantino, Francesca Pregnolato, Chelsea Bentow, et al.
Immunological Investigations|August 13, 2019
Two Novel Technologies for the Detection of Anti-cardiolipin and Anti β2-Glycoprotein Antibodies in the Real Life: Chemiluminescent in Comparison to the Addressable Laser Bead ImmunoassaysValentina Grossi, Maria Infantino, Maurizio Benucci, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2020
Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitisEwa Wunsch, Gary L Norman, Malgorzata Milkiewicz, et al.
Clinical and Experimental Rheumatology|August 4, 2017
Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseasesOra Shovman, Boris Gilburd, Chen Chayat, et al.
Autoimmunity Reviews|August 18, 2020
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndromeSavino Sciascia, Massimo Radin, Carlos Ramirez, et al.
Rheumatology (Oxford, England)|January 27, 2021
Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritisCeline Lamacchia, Delphine S Courvoisier, Matthias Jarlborg, et al.
Diagnostics (Basel, Switzerland)|April 13, 2023
Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative ReviewMarvin J Fritzler, Chelsea Bentow, Lorenzo Beretta, et al.
Plos One|November 15, 2014
PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC)Laura M Stinton, Chelsea Bentow, Michael Mahler, et al.
Immunologic Research|January 23, 2019
Tryptophan-kynurenine profile in pediatric autoimmune hepatitisSimon D Lytton, Marcin Osiecki, MałgorzataWoźniak, et al.
Autoimmunity Reviews|August 6, 2016
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center studyLucile Musset, Yves Allenbach, Olivier Benveniste, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Chemistry and Laboratory Medicine|July 19, 2019
Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experienceMaria Infantino, Francesca Pregnolato, Chelsea Bentow, et al.
Immunological Investigations|August 13, 2019
Two Novel Technologies for the Detection of Anti-cardiolipin and Anti β2-Glycoprotein Antibodies in the Real Life: Chemiluminescent in Comparison to the Addressable Laser Bead ImmunoassaysValentina Grossi, Maria Infantino, Maurizio Benucci, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2020
Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitisEwa Wunsch, Gary L Norman, Malgorzata Milkiewicz, et al.
Clinical and Experimental Rheumatology|August 4, 2017
Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseasesOra Shovman, Boris Gilburd, Chen Chayat, et al.
Autoimmunity Reviews|August 18, 2020
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndromeSavino Sciascia, Massimo Radin, Carlos Ramirez, et al.
Rheumatology (Oxford, England)|January 27, 2021
Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritisCeline Lamacchia, Delphine S Courvoisier, Matthias Jarlborg, et al.
Diagnostics (Basel, Switzerland)|April 13, 2023
Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative ReviewMarvin J Fritzler, Chelsea Bentow, Lorenzo Beretta, et al.
Plos One|November 15, 2014
PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC)Laura M Stinton, Chelsea Bentow, Michael Mahler, et al.
Immunologic Research|January 23, 2019
Tryptophan-kynurenine profile in pediatric autoimmune hepatitisSimon D Lytton, Marcin Osiecki, MałgorzataWoźniak, et al.
Autoimmunity Reviews|August 6, 2016
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center studyLucile Musset, Yves Allenbach, Olivier Benveniste, et al.
Pageof 4